|
|
|
front |1 |2 |3 |4 |5 |6 |7
|8 |9 |10 |11 |12 |13 |14 |15 |16 |17 |18 |19 |20 |21 |22 |23 |24 |25 |26 |27 |28 |29 |30 |31 |32 |33 |34 |35 |36 |37 |38 |39 |40 |41 |42 |43 |44 |45 |46 |47 |48 |review |
 |
Ronald B. Herberman, MD, the first director of the University of
Pittsburgh Cancer Institute, a National Cancer Institute
(NCI)-designated Comprehensive Cancer Center, is an internationally
recognized tumor immunologist who has made major discoveries in his
field and has fostered the application of this information to novel
approaches to cancer therapy.
|